Ricin and Shiga Toxins: Effects on Host Cell Signal Transduction

por Jandhyala, Dakshina M., Thorpe, Cheleste M., Magun, Bruce
Publicado 2011

Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin

por Thorpe, Cheleste M., Kane, Anne V., Chang, Justin, Tai, Albert, Vickers, Richard J., Snydman, David R.
Publicado 2018

1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial

por Vickers, Richard, Goldstein, Ellie J C, Citron, Diane, Snydman, David, Thorpe, Cheleste M, Kane, Anne V
Publicado 2018

2578. Narrow-Spectrum Antibiotic Treatment of Clostridium difficile Infection Improves Preservation of Intestinal Metabolic Profile

por Park, Seoyoung, Yanagi, Karin, Kane, Anne, Snydman, David R, Vickers, Richard, Thorpe, Cheleste M, Lee, Kyongbum
Publicado 2019

2567. Effect of Broad vs. Narrow-Spectrum Clostridioides difficile Treatment on Human Stool Bile Acid Composition Over Time

por Thorpe, Cheleste M, Qian, Xi, Yanagi, Karin, Kane, Anne, Alden, Nicholas, Snydman, David R, Lee, Kyongbum
Publicado 2019

A Novel Zak Knockout Mouse with a Defective Ribotoxic Stress Response

por Jandhyala, Dakshina M., Wong, John, Mantis, Nicholas J., Magun, Bruce E., Leong, John M., Thorpe, Cheleste M.
Publicado 2016

Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids

por Qian, Xi, Yanagi, Karin, Kane, Anne V., Alden, Nicholas, Lei, Ming, Snydman, David R., Vickers, Richard J., Lee, Kyongbum, Thorpe, Cheleste M.
Publicado 2020

Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin

por Wong, John, Smith, Logan B., Magun, Eli A., Engstrom, Thomas, Kelley-Howard, Kirsten, Jandhyala, Dakshina M., Thorpe, Cheleste M., Magun, Bruce E., Wood, Lisa J.
Publicado 2013

Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib

por Stone, Samuel M., Thorpe, Cheleste M., Ahluwalia, Amrita, Rogers, Arlin B., Obata, Fumiko, Vozenilek, Aimee, Kolling, Glynis L., Kane, Anne V., Magun, Bruce E., Jandhyala, Dakshina M.
Publicado 2012

1681 Randomized Clinical Trial of the Recovery of Probiotics Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis subspecies lactis (BB-12) from the Gastrointestinal (GI)...

por Poutsiaka, Debra D., Davidson, Lisa E., Stern, Lori Lathrop, Thorpe, Cheleste M., Kane, Anne V., Mahoney, Ian J., Mcdermott, Laura, Leyva, Rina, Goldin, Barry, Snydman, David R.
Publicado 2014

Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus

por Van, Nhi, Degefu, Yonatan N., Leus, Pathricia A., Larkins-Ford, Jonah, Klickstein, Jacob, Maurer, Florian P., Stone, David, Poonawala, Husain, Thorpe, Cheleste M., Smith, Trever C., Aldridge, Bree B.
Publicado 2023

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014

por Snydman, David R, McDermott, Laura A, Jenkins, Stephen G, Goldstein, Ellie J C, Patel, Robin, Forbes, Betty A, Johnson, Stuart, Gerding, Dale N, Thorpe, Cheleste M, Walk, Seth T
Publicado 2017